Aclaris Therapeutics Share Price (NASDAQ: ACRS)
$1.92
▲
0.08
(4.35%)
Last updated on
Check the interactive Aclaris Therapeutics Stock chart to analyse performance
Aclaris Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.81Today's High:$1.98
5.73%
Downside
Day's Volatility :8.35%
Upside
2.78%
- 52 Weeks Low:$1.0552 Weeks High:$5.17
45.31%
Downside
52 Weeks Volatility :79.69%
Upside
62.86%
Aclaris Therapeutics Stock Returns
Aclaris Therapeutics Inc Key Stats
Check Aclaris Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Aclaris Therapeutics Stock including INR - Dollar returns
The Aclaris Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aclaris Therapeutics investment value today
Current value as on today
₹1,72,241
Returns
₹72,241
(+72.24%)
Returns from Aclaris Therapeutics Stock
₹66,957 (+66.96%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Aclaris Therapeutics Stock
Global Institutional Holdings in Aclaris Therapeutics Inc
Name
Holdings %
BML Capital Management LLC
13.15%
Adage Capital Partners Gp LLC
8.89%
Vivo Capital, LLC
8.21%
Vanguard Group Inc
6.15%
Rock Springs Capital Management LP
4.40%
Millennium Management LLC
3.82%
Analyst Recommendation on Aclaris Therapeutics Stock
Hold
40%Buy
60%Hold
0%Sell
Based on 15 Wall street analysts offering stock ratings for Aclaris Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Aclaris Therapeutics Share Price Target
What analysts predicted
Upside of 309.22%
Target:
$7.86
Current:
$1.92
Aclaris Therapeutics share price target is $7.86, a slight Upside of 309.22% compared to current price of $1.92 as per analysts' prediction.
Aclaris Therapeutics Stock Insights
Price Movement
In the last 7 days, ACRS stock has moved up by 6.9%Increasing Revenue
Revenue is up for the last 2 quarters, 1.45M → 1.77M (in $), with an average increase of 18.1% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -15.08M → -15.42M (in $), with an average decrease of 2.3% per quarterACRS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 6.8%ACRS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 200.7%Price to Sales
ForACRS every $1 of sales, investors are willing to pay $11.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Aclaris Therapeutics Inc Financials
Aclaris Therapeutics Technicals Summary
Sell
Neutral
Buy
Aclaris Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Aclaris Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 25.82% | -1.79% | 67.39% | -88.82% | -17.38% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | -0.13 | -0.53 | -1.01 | -0.21 | NA | 1.22 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Hold | $199.3M | -17.38% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Aclaris Therapeutics Inc
Key Management of Aclaris Therapeutics Inc
Important FAQs about investing in ACRS Stock from India :
What is Aclaris Therapeutics share price today?
Aclaris Therapeutics share price today is $1.92 as on at the close of the market. Aclaris Therapeutics share today touched a day high of $1.98 and a low of $1.81.
What is the 52 week high and 52 week low for Aclaris Therapeutics share?
Aclaris Therapeutics share touched a 52 week high of $5.17 and a 52 week low of $1.05. Aclaris Therapeutics stock price today i.e. is closed at $1.92, lower by 62.86% versus the 52 week high.
How to invest in Aclaris Therapeutics Stock (ACRS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aclaris Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aclaris Therapeutics Shares that will get you 0.7813 shares as per Aclaris Therapeutics share price of $1.92 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Aclaris Therapeutics Stock (ACRS) from India?
Indian investors can start investing in Aclaris Therapeutics (ACRS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Aclaris Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Aclaris Therapeutics share’s latest price of $1.92 as on August 30, 2025 at 1:29 am IST, you will get 5.2083 shares of Aclaris Therapeutics. Learn more about
fractional shares .
What are the returns that Aclaris Therapeutics has given to Indian investors in the last 5 years?
Aclaris Therapeutics stock has given -17.38% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%